These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21147075)

  • 1. Neuroprotective effects of diallyl trisulfide in SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis.
    Guo Y; Zhang K; Wang Q; Li Z; Yin Y; Xu Q; Duan W; Li C
    Brain Res; 2011 Feb; 1374():110-5. PubMed ID: 21147075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective Effects of Genistein in a SOD1-G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
    Zhao Z; Fu J; Li S; Li Z
    J Neuroimmune Pharmacol; 2019 Dec; 14(4):688-696. PubMed ID: 31321663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
    Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
    J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis.
    Kim J; Kim TY; Cho KS; Kim HN; Koh JY
    Neurobiol Dis; 2013 Nov; 59():80-5. PubMed ID: 23891729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS.
    Haenggeli C; Julien JP; Mosley RL; Perez N; Dhar A; Gendelman HE; Rothstein JD
    Neurobiol Dis; 2007 Apr; 26(1):146-52. PubMed ID: 17276077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
    Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
    Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Preconditioning" with latrepirdine, an adenosine 5'-monophosphate-activated protein kinase activator, delays amyotrophic lateral sclerosis progression in SOD1(G93A) mice.
    Coughlan KS; Mitchem MR; Hogg MC; Prehn JH
    Neurobiol Aging; 2015 Feb; 36(2):1140-50. PubMed ID: 25443289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice.
    Schütz B; Reimann J; Dumitrescu-Ozimek L; Kappes-Horn K; Landreth GE; Schürmann B; Zimmer A; Heneka MT
    J Neurosci; 2005 Aug; 25(34):7805-12. PubMed ID: 16120782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of the cannabigerol quinone derivative VCE-003.2 in SOD1
    Rodríguez-Cueto C; Santos-García I; García-Toscano L; Espejo-Porras F; Bellido M; Fernández-Ruiz J; Muñoz E; de Lago E
    Biochem Pharmacol; 2018 Nov; 157():217-226. PubMed ID: 30076846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive Neuroprotective Effects of the Multifunctional Iron Chelator M30 with Enriched Diet in a Mouse Model of Amyotrophic Lateral Sclerosis.
    Golko-Perez S; Mandel S; Amit T; Kupershmidt L; Youdim MB; Weinreb O
    Neurotox Res; 2016 Feb; 29(2):208-17. PubMed ID: 26581376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of motor neuron degeneration by novel iron chelators in SOD1(G93A) transgenic mice of amyotrophic lateral sclerosis.
    Wang Q; Zhang X; Chen S; Zhang X; Zhang S; Youdium M; Le W
    Neurodegener Dis; 2011; 8(5):310-21. PubMed ID: 21346313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
    Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDP-choline is not protective in the SOD1-G93A mouse model of ALS.
    Knippenberg S; Skripuletz T; Rath KJ; Thau N; Gudi V; Pul R; Körner S; Dengler R; Stangel M; Petri S
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 May; 14(4):284-90. PubMed ID: 23286744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
    Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
    Apolloni S; Amadio S; Montilli C; Volonté C; D'Ambrosi N
    Hum Mol Genet; 2013 Oct; 22(20):4102-16. PubMed ID: 23736299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DL-3-n-butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis.
    Feng X; Peng Y; Liu M; Cui L
    Neuropharmacology; 2012 Feb; 62(2):1004-10. PubMed ID: 22056419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excessive and precocious glutamate release in a mouse model of amyotrophic lateral sclerosis.
    Raiteri L; Stigliani S; Zappettini S; Mercuri NB; Raiteri M; Bonanno G
    Neuropharmacology; 2004 May; 46(6):782-92. PubMed ID: 15033338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of thymic stimulation of CD4+ T cell expansion on disease onset and progression in mutant SOD1 mice.
    Sheean RK; Weston RH; Perera ND; D'Amico A; Nutt SL; Turner BJ
    J Neuroinflammation; 2015 Feb; 12():40. PubMed ID: 25889790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
    Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
    Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.